Tower Research Capital LLC (TRC) - CHEMOMAB THERAPEUTICS LTD ownership

CHEMOMAB THERAPEUTICS LTD's ticker is CMMB and the CUSIP is 16385C104. A total of 11 filers reported holding CHEMOMAB THERAPEUTICS LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CHEMOMAB THERAPEUTICS LTD
ValueSharesWeighting
Q3 2021$1,000
-50.0%
49
-35.5%
0.00%
Q1 2021$2,000760.00%
Other shareholders
CHEMOMAB THERAPEUTICS LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Orbimed Advisors 2,578,174$74,019,0000.69%
CVI Holdings, LLC 93,750$2,692,0000.19%
Maven Securities LTD 126,562$3,634,0000.16%
BOOTHBAY FUND MANAGEMENT, LLC 61,761$1,773,0000.07%
MEITAV INVESTMENT HOUSE LTD 8,311$239,0000.01%
Ironwood Financial, llc 167$5,0000.00%
Tower Research Capital LLC (TRC) 76$2,0000.00%
Renaissance Technologies 7,023$202,0000.00%
UBS Group AG 834$24,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CHEMOMAB THERAPEUTICS LTD shareholders